Using urology meetings to provide constant and consistent education regarding accepted clinical guidelines for screening low-risk prostate cancer patients results in a drop of unnecessary tests.
Consistent reminders about clinical guidelines for testing patients with low-risk prostate cancer deters unnecessary testing, according to a study published online in the Journal of the National Cancer Institute.
Curtailing unneeded medical tests is an important part of the Choosing Wisely Campaign, an initiative of the ABIM Foundation. Unnecessary medical tests contribute to the high cost of healthcare. The campaign’s goal is to reduce unnecessary tests and procedures, while supporting physicians to help patients make informed choices about their care.
Researchers from NYU Langone Medical Center sought to identify how to encourage fewer requests for unnecessary tests among patients with low-risk prostate cancer. “In the United States, we have guidelines about the overuse of imaging tests, but lack a roadmap for their implementation,” lead author Danil V. Makarov, MD, said in a release. Makarov is an assistant professor of urology and population health at the medical center.
Working with colleagues in Sweden, the researchers examined the records of approximately 100,000 Swedish men who had been diagnosed with prostate cancer from 1998 to 2009. Sweden’s National Prostate Cancer Registry (NPCR) introduced a campaign in 2000 aimed at clinicians to reduce the amount of inappropriate testing performed on men with low-risk prostate cancer. Local statistics on inappropriate imaging were presented at urology meetings, where the guidelines for imaging were repeatedly reviewed.
The results showed that this “public shaming” of sorts had a significant effect on the number of inappropriate tests performed after the campaign began, dropping from 45 percent to 3 percent among low-risk patients. However, Makarov pointed out that appropriate scanning among high-risk patients dropped as well, from 63 percent to 46 percent, unfortunately.
“The caveat here is that when guidelines are implemented to limit the inappropriate use of a healthcare resource, the appropriate use of that resource should be simultaneously encouraged - otherwise those patients who most need the resource may no longer have access to it,” Makarov said. “But the true lesson from this study is that inappropriate utilization of healthcare resources can be reduced by giving feedback to practitioners.”
Emerging AI Algorithm Shows Promise for Abbreviated Breast MRI in Multicenter Study
April 25th 2025An artificial intelligence algorithm for dynamic contrast-enhanced breast MRI offered a 93.9 percent AUC for breast cancer detection, and a 92.3 percent sensitivity in BI-RADS 3 cases, according to new research presented at the Society for Breast Imaging (SBI) conference.
The Reading Room Podcast: Current Perspectives on the Updated Appropriate Use Criteria for Brain PET
March 18th 2025In a new podcast, Satoshi Minoshima, M.D., Ph.D., and James Williams, Ph.D., share their insights on the recently updated appropriate use criteria for amyloid PET and tau PET in patients with mild cognitive impairment.
Can Abbreviated Breast MRI Have an Impact in Assessing Post-Neoadjuvant Chemotherapy Response?
April 24th 2025New research presented at the Society for Breast Imaging (SBI) conference suggests that abbreviated MRI is comparable to full MRI in assessing pathologic complete response to neoadjuvant chemotherapy for breast cancer.
Clarius Mobile Health Unveils Anterior Knee Feature for Handheld Ultrasound
April 23rd 2025The T-Mode Anterior Knee feature reportedly offers a combination of automated segmentation and real-time conversion of grayscale ultrasound images into color-coded visuals that bolster understanding for novice ultrasound users.